Home -
Products -
Others -
Other Targets -
1,3-Dihydroxy-2,7,8-trimethoxy-6-methyl-9,10-anthracenedione
1,3-Dihydroxy-2,7,8-trimethoxy-6-methyl-9,10-anthracenedione
CAS No. 1622982-59-5
1,3-Dihydroxy-2,7,8-trimethoxy-6-methyl-9,10-anthracenedione( ——— )
Catalog No. M38226 CAS No. 1622982-59-5
6,8-Dihydroxy-1,2,7-trimethoxy-3-methylanthraquinone (compound 1) is an anthraquinone α-glucosidase inhibitor (IC50:185 μM), which can be isolated from Cassia seeds.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name1,3-Dihydroxy-2,7,8-trimethoxy-6-methyl-9,10-anthracenedione
-
NoteResearch use only, not for human use.
-
Brief Description6,8-Dihydroxy-1,2,7-trimethoxy-3-methylanthraquinone (compound 1) is an anthraquinone α-glucosidase inhibitor (IC50:185 μM), which can be isolated from Cassia seeds.
-
Description6,8-Dihydroxy-1,2,7-trimethoxy-3-methylanthraquinone (compound 1) is an anthraquinone α-glucosidase inhibitor (IC50:185 μM), which can be isolated from Cassia seeds.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
RecptorIC50: 185 μM (α-Glucosidase)
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number1622982-59-5
-
Formula Weight344.32
-
Molecular FormulaC18H16O7
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Xu YL, et al. Five new anthraquinones from the seed of Cassia obtusifolia. Arch Pharm Res. 2015 Jun;38(6):1054-8.?
molnova catalog
related products
-
1-Hydroxybaccatin I
1-Hydroxybaccatin I possesses significant antinociceptive activity against p- benzoquinone-induced abdominal contractions.
-
Naratuximab
Naratuximab emtansine is a humanized monoclonal antibody (Anti-TSPAN26/CD37 Reference Antibody (naratuximab)) that specifically targets CD37 (TSPAN26) and serves as the basis for creating an antibody-drug conjugate (ADC) compound.
-
Clozic
Clozic exhibits reversible anti-proliferative effects and can be used in studies about serving as a potential anti-arthritic agent.
Cart
sales@molnova.com